Retinol-binding protein 4 and lipocalin-2 in childhood and adolescent obesity: When children are not just "small adults"

Clinical Chemistry

Volumn 54, Issue 7, 2008, Pages 1176-1182

  Kanaka Gantenbein, Christina ^a   Margeli, Alexandra ^b   Pervanidou, Panagiota ^a   Sakka, Sophia ^a   Mastorakos, George ^a   Chrousos, George P ^a   Papassotiriou, Ioannis ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; LEPTIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PREALBUMIN; RETINOL BINDING PROTEIN 4;

ADOLESCENT; ARTICLE; BODY MASS; CHILD; CONCENTRATION (PARAMETERS); CORRELATION FUNCTION; FEMALE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MEASUREMENT; OBESITY;

ACUTE-PHASE PROTEINS; ADIPONECTIN; ADOLESCENT; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CHILD; FEMALE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; LEPTIN; LIPOCALINS; OBESITY, MORBID; PROTO-ONCOGENE PROTEINS; RETINOL-BINDING PROTEINS, PLASMA;

EID: 47549089272     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.099002     Document Type: Article

References (33)

1. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89: 2548-56.
2. Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin and resistin. Clin Chem 2004;50: 1511-25.
3. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356-62.
4. Graham TE, Yang Q, Blueher M, Hammarstedt A, Ciaraldi TP, Henry RR, et al. Retinol-binding protein 4 and insulin resistance in lean, obese and diabetic subjects. N Engl J Med 2006;354: 2552-63.
5. Polonsky KS. Retinol-binding protein 4, insulin resistance and type 2 diabetes. N Engl J Med 2006;354:2596-8.
6. Munkhtulga L, Nakayama K, Utsumi N, Yanagisawa Y, Gotoh T, Omi T, et al. Identification of a regulatory SNP in the retinol binding protein 4 gene associated with type 2 diabetes in Mongolia. Hum Genet 2007;120:879-88.
7. Janke J, Engeli S, Boschmann M, Adams F, Boehnke J, Luft FC, et al. Retinol-binding protein 4 in human obesity. Diabetes 2006;55: 2805-10.
8. Lee DC, Lee JW, Im JA. Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents. Metabolism 2007;56:327-31.
9. Balagopal P, Graham TE, Kahn BB, Altomare A, Funanage V, George D. Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. J Clin Endocrinol Metab 2007;92: 1971-4.
10. Wang Y, Lam KS, Kraegen EW, Sweeney G, Zhang I, Tso AW, et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance and hyperglycemia in humans. Clin Chem 2007;53:34-41.
11. van Dam RM, Hu FB. Lipocalins and insulin resistance: etiological role of retinol-binding protein 4 and lipocalin-2? Clin Chem 2007;53:5-7.
12. Yan Q-W, Yang Q, Mody N, Graham TE, Hsu C-H, Xu Z, et al. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 2007;56:2533-40.
13. Cho YM, Youn B-S, Lee H, Lee N, Min S-S, Kwak SH, et al. Plasma retinol-binding protein 4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 2006;29:2457-61.
14. World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: World Health Organization, 1998.
15. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000;320:1-6.
16. Chiotis D, Krikos X, Tsiftis G, Hatzisymeon M, Maniati-Christidi M, Dacou-Voutetaki A. Body mass index and prevalence of obesity in subjects of Hellenic origin aged 0-18 years living in the Athens area. Ann Clin Pediatr Unive Atheniensis 2004;51:139-54.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
18. Graham TE, Wason CJ, Bluher M, Kahn BB. Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects. Diabetologia 2007;50:814-23.
19. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes and the metabolic syndrome. J Clin Invest 2006;116:1784-92.
20. Bacha F, Saad R, Gungor N, Arslanian SA. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity and beta-cell function. Diabetes Care 2004;27:547-52.
21. Winer JC, Zern TL, Taksali SE, Dziura J, Gali AM, Wollschlager M, et al. Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. J Clin Endocrinol Metab 2006;91:4415-23.
22. Reinehr T, Roth C, Menke T, Andler W. Adiponec-tin before and after weight loss in obese children. J Clin Endocrinol Metab 2004;89:3790-4.
23. Retnakaran R, Hansley AJG, Connelly PW, Harris SB, Zinman B. Elevated C-reactive protein in native Canadian children: an ominous early complication of childhood obesity. Diabetes Obesity Metab 2006;8:483-91.
24. Tamori Y, Sakaue H, Kasuga M. RBP4, an expected adipokine. Nat Med 2005;12:30-1.
25. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000;106:473-81.
26. Shepherd PR, Kahn BB. Glucose transporters and insulin action - implications for insulin resistance and diabetes mellitus. N Engl J Med 1999;341: 248-57.
27. Yao-Borengasser A, Varma V, Bodles AM, Rasouli N, Phanavahn B, Lee MJ, et al. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation and response to pioglitazone. J Clin Endocrinol Metab 2007;92: 2590-7.
28. McTernan PG, Kumar S. Retinol binding protein 4 and pathogenesis of diabetes. J Clin Endocrinol Metab 2007;92:2430-2.
29. Monaco HL. The transthyretin-retinol binding protein complex. Biochim Biophys Acta 2000;1482: 65-72.
30. Naylor HM, Newcomer ME. The structure of human retinol-binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP. Biochemistry 1999; 38:2647-53.
31. Basu TK, Basualdo C. Vitamin A homeostasis and diabetes mellitus. Nutrition 1997;13:804-6.
32. Gavi S, Stuart LM, Kelly P, Melendez MM, Mynarcik DC, Gelato MC, McNurlan MA. Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes. J Clin Endocrinol Metab 2007;92:1886-90.
33. Shin MJ, Kang SM, Jang Y, Lee JH, Oh J, Chung JH, Chung N. Serum retinol binding protein 4 levels are associated with serum adiponectin levels in non-diabetic, non-obese subjects with hypercholesterolemia. Clin Chim Acta 2007;378: 227-9.